IM Pharma SRL
0.7 FTEIM Pharma reported total assets of €1.24m at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jul 2026), with 0.7 full-time equivalent.
The score of IM Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -1 % Total assets +20 % Headcount (avg FTE) +17 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
IM Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 175,169 € | ||||
| Equity | 728,784 € | ||||
| Cash | 643,740 € | ||||
| EBITDA | 277,851 € | ||||
| Total assets | €1.24m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jul 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 31 Jul 2024
- Year ended 31 Dec 2022filed on 28 Jul 2023
- Year ended 31 Dec 2021filed on 27 Jul 2022
IM Pharma's financial analysis
- Solvency59.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of IM Pharma
IM Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0816.908.858
- VAT number
- BE0816908858
- Peppol
- Registered · 0208:0816908858 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Jun 2009
- Registered office
- 8480 Ichtegem
- Size
- Micro · 0.7 FTE
- Latest accounts
- 2025 · filed on 29 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
IM Pharma (SRL) has been based in Ichtegem since 2009, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 175,169 € and equity of 728,784 €; its revenue is not published. With 0.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 59.0%, above the median of its sector (44.2%).
Companies similar to IM Pharma
Companies in the same business, of comparable size and area, outside its group.
- Niemegeers-Engels BV Retail sale of pharmaceutical products Asse · balance sheet €1.23m
- Pharmacie DU Recif Retail sale of pharmaceutical products Ixelles · balance sheet €1.23m
- Apotheek Ameloot Retail sale of pharmaceutical products Machelen (Brab.) · balance sheet €1.24m
- Bauphar Retail sale of pharmaceutical products Rebecq · balance sheet €1.24m
- Vandenabeele-Hungenaert Retail sale of pharmaceutical products Damme · balance sheet €1.23m
- Apoteek Rigaux Retail sale of pharmaceutical products Merelbeke-Melle · balance sheet €1.25m
- Aclot Pharma Retail sale of pharmaceutical products Nivelles · balance sheet €1.22m
- Groenenhoek Retail sale of pharmaceutical products Antwerp · balance sheet €1.25m
Frequently asked questions about IM Pharma
What is the revenue of IM Pharma?
IM Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of IM Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0816908858 for IM Pharma, if the company is VAT-registered. Its company number (CBE) is 0816.908.858.
Where is the registered office of IM Pharma?
According to the CBE register, the registered office of IM Pharma is in 8480 Ichtegem.
What is the equity of IM Pharma?
At the close of the 2025 financial year, the equity of IM Pharma amounts to 728,784 €, a solvency of 59.0% of total assets.
How many people work at IM Pharma?
0.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages IM Pharma?
The register lists 2 active mandates at IM Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of IM Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →